SELLAS Life Sciences Group, Inc.【SLS】 利益剰余金の推移

機能の使い方
(単位:千ドル) 利益剰余金 前年比(%)
1Q25 -253,900 +11.9%
4Q24 -248,100 +14.2%
3Q24 -241,400 +15.4%
2Q24 -234,300 +17.3%
1Q24 -226,800 +18.7%
4Q23 -217,200 +20.7%
3Q23 -209,100 +22.4%
2Q23 -199,800 +22.0%
1Q23 -191,000 +23.0%
4Q22 -179,900 +29.8%
3Q22 -170,800 +29.4%
2Q22 -163,800 +31.1%
1Q22 -155,300 +29.1%
4Q21 -138,600 +17.6%
3Q21 -132,000 +15.6%
2Q21 -124,900 +13.9%
1Q21 -120,300 +14.2%
4Q20 -117,900 +16.6%
3Q20 -114,200 +21.8%
2Q20 -109,700 +22.5%
1Q20 -105,300 +21.9%
4Q19 -101,100 +23.5%
3Q19 -93,728 +36.8%
2Q19 -89,526 +31.2%
1Q19 -86,392 +38.9%
4Q18 -81,855 +51.1%
3Q18 -68,532 -79.2%
2Q18 -68,242 -78.9%
1Q18 -62,180 -
4Q17 -54,185 -
3Q17 -329,129 -
2Q17 -323,054 -
2Q11 -60,970 -